U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
190696190696High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat CancerCompletedNo Results AvailableHead and Neck CancerDrug: cisplatin|Drug: fluorouracil|Procedure: adjuvant therapy|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00052429
190697190697Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCompletedNo Results AvailableLeukemia|LymphomaDrug: thalidomidehttps://ClinicalTrials.gov/show/NCT00052416
190698190698Monoclonal Antibody Therapy in Treating Patients With Advanced Solid TumorsWithdrawnNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: monoclonal antibody anti-anb3 integrin|Procedure: anti-cytokine therapy|Procedure: antiangiogenesis therapy|Procedure: antibody therapy|Procedure: biological response modifier therapy|Procedure: growth factor antagonist therapy|Procedure: monoclonal antibody therapyhttps://ClinicalTrials.gov/show/NCT00052403
190699190699Doxorubicin and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Soft Tissue SarcomaCompletedNo Results AvailableSarcomaBiological: bevacizumab|Drug: doxorubicin hydrochloridehttps://ClinicalTrials.gov/show/NCT00052390
190700190700Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis FungoidesTerminatedNo Results AvailableRecurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Mycosis Fungoides/Sezary Syndrome|Stage I Cutaneous T-cell Non-Hodgkin Lymphoma|Stage I Mycosis Fungoides/Sezary Syndrome|Stage II Cutaneous T-cell Non-Hodgkin Lymphoma|Stage II Mycosis Fungoides/SBiological: aldesleukin|Biological: recombinant interleukin-12|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00052377
190701190701Oxaliplatin in Treating Patients With Liver CancerCompletedNo Results AvailableAdult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver CancerDrug: oxaliplatin|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00052364
190702190702Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast CancerCompletedNo Results AvailableBreast CancerBiological: recombinant fowlpox-CEA(6D)/TRICOM vaccine|Biological: recombinant vaccinia-CEA(6D)-TRICOM vaccine|Biological: sargramostim|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: paclitaxel|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00052351
190703190703Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerCompletedNo Results AvailableMalignant Pleural Effusion|Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung CancerDrug: gemcitabine hydrochloride|Drug: carboplatin|Drug: bortezomib|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00052338
190704190704Mistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative ChemotherapyActive, not recruitingNo Results AvailableLung CancerDietary Supplement: mistletoe extracthttps://ClinicalTrials.gov/show/NCT00052325
190705190705Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial CancerCompletedNo Results AvailableEndometrial CancerDrug: cisplatin|Drug: doxorubicin hydrochloride|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00052312
190681190681Technetium Tc 99m Sulfur Colloid and Blue Dye In Detecting Sentinel Lymph Nodes in Patients With Breast CancerCompletedNo Results AvailableBreast CancerDrug: patent blue V dye|Procedure: radionuclide imaging|Procedure: sentinel lymph node biopsy|Radiation: technetium Tc 99m sulfur colloidhttps://ClinicalTrials.gov/show/NCT00052676
190706190706Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid LeukemiaCompletedNo Results AvailableLeukemiaDrug: cytarabine|Drug: etoposide|Drug: gemtuzumab ozogamicin|Drug: idarubicin|Drug: mitoxantrone hydrochloridehttps://ClinicalTrials.gov/show/NCT00052299
190707190707Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain CancerCompletedNo Results AvailableBrain and Central Nervous System Tumors|Cognitive/Functional Effects|FatigueDrug: modafinilhttps://ClinicalTrials.gov/show/NCT00052286
190708190708LY317615 Plus Capecitabine in Treating Patients With Advanced Solid TumorsCompletedNo Results AvailableAdult|Solid TumorDrug: capecitabine|Drug: enzastaurin hydrochloridehttps://ClinicalTrials.gov/show/NCT00052273
190709190709Epoetin Alfa in Treating Fatigue in Patients With Advanced Solid Tumors Who Are Not Receiving ChemotherapyWithdrawnNo Results AvailableFatigue|Unspecified Adult Solid Tumor, Protocol SpecificBiological: epoetin alfahttps://ClinicalTrials.gov/show/NCT00052221
190710190710Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma MultiformeCompletedNo Results AvailableAdult Giant Cell Glioblastoma|Adult Glioblastoma|Adult GliosarcomaDrug: gefitinib|Radiation: radiation therapy|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00052208
190682190682Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder CancerCompletedNo Results AvailableBladder CancerDrug: hexaminolevulinate|Procedure: biopsy|Procedure: cystoscopyhttps://ClinicalTrials.gov/show/NCT00052637
190683190683Immunotoxin Therapy in Treating Children With Progressive or Recurrent Glioblastoma Multiforme or Anaplastic AstrocytomaActive, not recruitingNo Results AvailableBrain and Central Nervous System TumorsBiological: transferrin-CRM107https://ClinicalTrials.gov/show/NCT00052624
190684190684Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck DysplasiaActive, not recruitingNo Results AvailableHead and Neck CancerDrug: celecoxibhttps://ClinicalTrials.gov/show/NCT00052611
190685190685Therapeutic Autologous Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell TransplantTerminatedNo Results AvailableAccelerated Phase Chronic Myelogenous Leukemia|Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Biological: therapeutic allogeneic lymphocytes|Biological: aldesleukin|Other: laboratory biomarker analysis|Other: flow cytometryhttps://ClinicalTrials.gov/show/NCT00052598
190686190686Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal CancerTerminatedNo Results AvailableAdenocarcinoma of the Colon|Adenocarcinoma of the Rectum|Mucinous Adenocarcinoma of the Colon|Mucinous Adenocarcinoma of the Rectum|Recurrent Colon Cancer|Recurrent Rectal Cancer|Signet Ring Adenocarcinoma of the Colon|Signet Ring Adenocarcinoma of the ReDrug: irinotecan hydrochloride|Drug: gefitinib|Drug: leucovorin calcium|Drug: fluorouracilhttps://ClinicalTrials.gov/show/NCT00052585
190687190687Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative DisordersCompletedNo Results AvailableLeukemia|LymphomaDrug: ixabepilonehttps://ClinicalTrials.gov/show/NCT00052572
190688190688Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal CancerCompletedNo Results AvailableAdenocarcinoma of the Rectum|Stage II Rectal Cancer|Stage III Rectal CancerBiological: bevacizumab|Drug: fluorouracil|Radiation: external beam radiation therapy|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00052559
190689190689Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell TransplantationCompletedNo Results AvailableAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21Biological: therapeutic allogeneic lymphocytes|Biological: aldesleukin|Procedure: peripheral blood stem cell transplantation|Procedure: allogeneic bone marrow transplantation|Other: laboratory biomarker analysis|Genetic: gene expression analysis|Other: immunologic technique|Other: flow cytometry|Genetic: polymerase chain reaction|Genetic: cytogenetic analysis|Other: staining methodhttps://ClinicalTrials.gov/show/NCT00052520
190690190690Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal CancerCompletedNo Results AvailableColorectal CancerDrug: bortezomibhttps://ClinicalTrials.gov/show/NCT00052507
190691190691Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: cisplatin|Drug: imatinib mesylate|Drug: irinotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00052494
190692190692Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate CancerCompletedNo Results AvailableProstate CancerProcedure: quality-of-life assessmenthttps://ClinicalTrials.gov/show/NCT00052481
190693190693Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube CancerCompletedNo Results AvailableFallopian Tube Cancer|Ovarian CancerDrug: TCG|Drug: TChttps://ClinicalTrials.gov/show/NCT00052468
190694190694Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant GliomaCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: lomustine|Drug: procarbazine hydrochloride|Drug: temozolomide|Drug: vincristine sulfatehttps://ClinicalTrials.gov/show/NCT00052455
19069519069510-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's LymphomaCompletedNo Results AvailableLymphomaDrug: pralatrexatehttps://ClinicalTrials.gov/show/NCT00052442

* Görseller ve İçerik tekif hakkına sahip olabilir